News | Mental health

News

Just over half of places filled on specialist mental health training for pharmacists

Exclusive: The University of Bradford has confirmed that 55% of places were filled in the first year of its ‘Specialist mental health pharmacist training pathway’.…

Published: 9 January 2024

Feature

Revisiting 2023: a look back at the year in pharmacy

In this episode, The PJ team take a look back at 2023 in pharmacy before sharing their predictions for the year ahead.…

Published: 20 December 2023

Opinion

Learning and CPD: 2023 in review

Here, we look back on some of the highlights from research and learning content published in 2023 by The Pharmaceutical Journal and celebrate the valuable contributions made by our expert authors and reviewers.…

Published: 19 December 2023

Opinion

Community pharmacies’ full potential is trapped in an iron cage of bureaucracy

A community pharmacy mental health service piloted in Lincolnshire is funded on a flat fee, which the authors argue creates a service model that allows them to offer care regardless of the number of patients they see.…

Published: 13 December 2023

News

Safety measures introduced for isotretinoin prescribing in patients aged under 18 years

Recommendations to improve the safety of prescribing the acne drug isotretinoin have been made by the Commission on Human Medicines.…

Published: 1 November 2023

Letter

Exploring the safe and effective tapering solutions in the NHS

There has been a growing consensus that the safest approach to discontinuing psychiatric medicines is through a gradual and hyperbolic tapering process. This concept is thoroughly explained in the informative article authored by Mark Horowitz and David Taylor entitled 'Case-based learning: safe with…

Published: 10 October 2023

News

Burnout among pharmacy professionals needs to be addressed at ‘systemic level’, RPS report finds

The report stated that individuals should seek to prioritise their wellbeing, but highlighted that many factors affecting staff wellbeing have been created by the healthcare system.…

Published: 6 October 2023

News

Esketamine outperforms quetiapine for treatment-resistant depression, study finds

Patients with treatment-resistant depression, who received esketamine nasal spray plus an antidepressant, were more likely to achieve remission at eight weeks than those who received quetiapine and an antidepressant, according to trial results.…

Published: 5 October 2023

Feature

Rapid-acting antidepressants face a slow journey to wider use

Evidence is mounting for the effectiveness of rapid-acting antidepressants for treatment-resistant depression — but will their use ever take off in the NHS?…

Published: 21 September 2023

News

NICE recommends drug treatment for long-term insomnia

Daridorexant has been recommended as a second-line treatment for long-term insomnia by the National Institute for Health and Care Excellence.…

Published: 15 September 2023